News from omeros corporation A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( Bloomberg:RTRKS,RICS:RTRKS)

Nov 19, 2014, 07:00 ET

OMS721 Inhibits Thrombus Formation in Sera from aHUS Patients

 Omeros Corporation (NASDAQ: OMER) today announced positive data using OMS721, the lead human monoclonal antibody for its mannan-binding...

Nov 10, 2014, 16:02 ET

Omeros Corporation Reports Third Quarter 2014 Financial Results

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Nov 06, 2014, 07:00 ET

Omeros Announces Positive Data for MASP-2 Inhibitor in Experimental Model of Stroke

Omeros Corporation (NASDAQ: OMER) today announced positive data using a derivative of OMS721 in a well-established animal model of stroke. OMS721...

Nov 04, 2014, 07:00 ET

Omeros Corporation to Announce Third Quarter 2014 Financial Results on November 10, 2014

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Oct 30, 2014, 07:00 ET

Omidria™ Granted Pass-Through Reimbursement Status from CMS

Omeros Corporation (NASDAQ: OMER) announced today that it has received transitional pass-through status for its lead product Omidria™...

Oct 21, 2014, 07:00 ET

Omeros Provides Update on PDE10 Inhibitor Program

 Omeros Corporation (NASDAQ: OMER) today provided an update on OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor in development for...

Aug 11, 2014, 16:03 ET

Omeros Corporation Reports Second Quarter 2014 Financial Results

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein...

Aug 08, 2014, 07:00 ET

Omeros to Present at the Wedbush PacGrow 2014 Life Sciences Management Access Conference

Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...

Jun 02, 2014, 07:00 ET

Omeros Receives FDA Approval of Omidria™ for Use in Cataract and Other Intraocular Lens Replacement Procedures

Omeros Corporation (NASDAQ: OMER) today announced that the U.S. Food and Drug Administration (FDA) has approved Omidria™ (phenylephrine and...

May 12, 2014, 16:05 ET

Omeros Corporation Reports First Quarter 2014 Financial Results

Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing...

Apr 07, 2014, 07:00 ET

Omeros to Present at the 13th Annual Needham Healthcare Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...

Apr 03, 2014, 07:00 ET

Investigational New Drug Application Cleared by FDA for OMS721 in Thrombotic Microangiopathies

 Omeros Corporation (NASDAQ: OMER) today announced that its Investigational New Drug Application (IND) to evaluate OMS721 for the inhibition of...

Apr 01, 2014, 07:00 ET

Omeros Invited to Present on OMS824 Phase 2 Clinical Program at the Schizophrenia International Research Conference

 Omeros Corporation (NASDAQ: OMER) today announced that the company was invited by the organizers of the 2014 Biennial Conference of the...

Mar 21, 2014, 07:00 ET

Omeros to Present at BioCentury Future Leaders in the Biotech Industry Conference

 Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on...

Mar 19, 2014, 17:19 ET

Omeros Closes $40.25 Million Public Offering of Common Stock

 Omeros Corporation (NASDAQ: OMER) today announced that it has closed the underwritten public offering that was priced and allocated to...

Mar 14, 2014, 08:33 ET

Omeros Prices $35.0 Million Public Offering of Common Stock

 Omeros Corporation (NASDAQ: OMER) today announced that it has priced an underwritten public offering of 3,043,479 shares of its common...

Mar 13, 2014, 16:36 ET

Omeros Announces Proposed Public Offering of Common Stock

 Omeros Corporation (NASDAQ: OMER) today announced its intention to offer, subject to market and other conditions, shares of its common stock...

Mar 13, 2014, 16:16 ET

Omeros Corporation Reports Fourth Quarter and Year-End 2013 Financial Results

Omeros Corporation (NASDAQ: OMER), a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing...

Mar 10, 2014, 07:00 ET

Omeros Announces Positive OMS721 Data in Serum from Patients with aHUS

 Omeros Corporation (NASDAQ: OMER) today announced positive data using OMS721, the lead human monoclonal antibody in Omeros' mannan-binding...

Mar 06, 2014, 07:00 ET

Omeros Reports Additional Positive Data from its OMS824 Phase 2a Schizophrenia Clinical Trial

Omeros Corporation (NASDAQ: OMER) today announced additional positive results from a Phase 2a clinical trial of OMS824, the company's...